Inputs: momentum, trendVelocity
Mixed signal: momentum 58/100, trend 54/100.
Prediction result · Ensemble engineUpdated 3:01 AM
ABBVABBV stock price outlook
$294.78+1.55% since prev closeBullish
ABBV is up 1.55% since the previous close on the latest cached quote at $294.78. Mixed signal: momentum 58/100, trend 54/100.
Universal leanStock
ABBV
ABBV
$294.78+1.55%
LEANSOFT mild bid
WHY
- ABBV is up 1.55% since the previous close on the latest cached quote at $294.78. Mixed signal: momentum 58/100, trend 54/100.
- Bull input: Sentiment 65/100 with price up 1.6% confirms catalyst follow-through.
RISK
Quote row is current from the latest cached feed.
INVALIDATE
Invalidate on a decisive break of the session bid, catalyst reversal, or model edge flipping bearish.
AI Signal
Bullish · Bullish setup
live data
Cached quote refreshed 2026-11-02T03:01:02.689Z. Change is measured since the previous close.
Quote source
Cron batch chart feed 2026-11-02T03:01:02.689Z
Move since previous close
+1.55%
News Sentiment65/100
Price Momentum58/100
Trend Velocity54/100
Volatility Risk46/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on ABBV
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgePlayableNeutral
Inputs: newsSentiment, dayChange
Sentiment 65/100 with price up 1.6% confirms catalyst follow-through.
Inputs: unusualVolume, dayChange
Volume read 45/100 with price drift 1.6% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 46/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Mid-range positioning — no edge from range alone.
Inputs: newsSentiment, weekChange
Sentiment 65/100 vs week change 2.8% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 0.0% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 56 — healthy uptrend region.
Inputs: momentum, dayChange, vsSma50
Momentum 58/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 65/100 and weekly change 2.8% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 45/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 46/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 59% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 65/100 and momentum 58/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance 0.0% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 56 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 58/100, trend 54/100.
- Price within 0.0% of the 50d SMA — no clear structural read.
- Momentum 58/100 is not strong enough to confirm a breakout.
Counter-trees
- Sentiment 65/100 with price up 1.6% confirms catalyst follow-through.
- Oscillator at 56 — healthy uptrend region.
Bull Case
- Sentiment 65/100 with price up 1.6% confirms catalyst follow-through.
- Oscillator at 56 — healthy uptrend region.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
The Motley Fool64
Is AbbVie a buy after its latest earnings report?
10/31/2026, 8:17:39 AM
Yahoo Finance69
AbbVie Stock Hits a Record After a 5.2% Dividend Raise: Why Its 276% Payout Ratio Doesn’t Tell the Entire Story
11/1/2026, 6:38:00 AM
24/7 Wall St.62
AbbVie Stock: What 10 Years of Growth and Dividends Did for $1,000
10/29/2026, 11:17:00 AM
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Market cap
- $521.11B
- 52-week range
- $292.67/$190.75
- Volume
- 6,898,187
- Avg volume
- 7,233,543
- Analyst 1-yr target
- $288.00
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Not yet scheduled
Estimate
N/A
Actual
$3.65
- • Last report Jul 31, 2026 (Jun 2026): EPS $3.65 vs $3.64 expected, +0.27% surprise.
- • Beat estimates in 4 of the last 4 quarters.
Risk Warnings
- • Quote row is current from the latest cached feed.
- • Quotes can be delayed. Research only, not investment advice.
ABBV questions
What is the MarketPicks AI signal for ABBV stock (ABBV)?
As of Nov 1, 10:01 PM ET, the ensemble reads bullish on ABBV — bullish — 2 of 16 bots up, with 2 bull, 0 bear and 14 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest ABBV price on MarketPicks?
ABBV was $294.78 on the latest quote (Nov 1, 10:01 PM ET), +1.55% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for ABBV mean?
Scores run from 0 to 100, with 50 neutral. ABBV shows momentum 58/100, trend velocity 54/100 and volatility risk 46/100, with news sentiment at 65/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.